Harvard’s first-ever Special Report on Longevity (quick share + small ask)
David Barzilai MD PhD
Dear Lifeboat Foundation Advisory Colleagues,
A field-level milestone worth sharing, and a quick ask attached.
Harvard Medical School has published its first-ever Special Health Report on Longevity. I served as Medical Editor. This is the first time a major US academic institution has produced a comprehensive, evidence-based consumer health report dedicated to longevity science under its institutional imprint. The report covers the biology of aging, the hallmarks framework, healthspan strategies, lifestyle medicine foundations, and the emerging gerotherapeutic pipeline (rapamycin, metformin, senolytics, GLP-1s, and cellular and epigenetic reprogramming, among others).
For a group working at the frontier of longevity advocacy and science, this kind of mainstream institutional anchoring matters. Decades of work by this community and others to position geroscience as a coherent medical discipline are arriving at a meaningful inflection point. The more this milestone reaches the people who can build on it (researchers, clinicians, investors, policymakers, advocates), the more momentum it can generate for the next phase of the field’s maturation.
The LinkedIn announcement with the full team and scope is here:
The small ask: a repost or substantive engagement from anyone here would extend the reach into networks that need to find this. Even forwarding to one or two colleagues who would benefit from knowing would be genuinely appreciated. This field has been built by groups like this one over decades, and this milestone belongs to all of us.
Sincerely,
Lecturer, Harvard Medical School
Faculty & Trustee, Geneva College of Longevity Science
Rodolfo Goya
--
You received this message because you are subscribed to the Google Groups "Lifeboat Foundation Advisory Boards" group.
To unsubscribe from this group and stop receiving emails from it, send an email to lifeboat-advisory-...@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/lifeboat-advisory-boards/CAMLVB1bLChAnC00hCAtd0OCHtgCB%3DUtvZetjVCyTBsfe%3Dk9jxA%40mail.gmail.com.
Shams Hamid
Dear David,
Thank you for sharing this milestone, and congratulations on your role as Medical Editor.
What strikes me most is not only the publication itself, but what it represents for the evolution of the field. Harvard's engagement signals that geroscience is increasingly being treated as a coherent medical and scientific discipline rather than an emerging collection of promising ideas. That transition carries significant implications for researchers, clinicians, policymakers, and the public alike.
Reading the report from the perspective of our work in Relational Intelligence, I was particularly drawn to the underlying shift from disease-centered medicine toward systems-oriented thinking. Aging is increasingly being understood not as a collection of isolated pathologies, but as a set of interconnected processes that shape multiple outcomes simultaneously. In many ways, this mirrors a broader movement across disciplines toward understanding complex systems through relationships rather than isolated components.
The report also prompted several questions that I suspect may become increasingly important as the field matures:
As longevity science moves from extending lifespan toward extending healthspan, how might we begin measuring what could be called "relational health" — the quality of social connection, meaning, belonging, and intergenerational contribution that make additional years valuable?
If the hallmarks of aging become the dominant framework for preventive medicine, what complementary frameworks will be needed to address the social, psychological, and relational dimensions of human flourishing that biology alone cannot fully explain?
Looking twenty years ahead, what do you believe is the most likely future trajectory of the field? Will longevity medicine remain primarily a clinical specialty focused on biological interventions, or do you foresee it evolving into a broader paradigm of human development that integrates biological, behavioral, social, and environmental determinants of healthy longevity?
From a futures perspective, this last question feels particularly important. Many transformative fields reach a point where their greatest challenges become institutional and societal rather than purely scientific. I wonder whether longevity science may be approaching that phase.
Thank you again for sharing this achievement. I appreciate the decades of work by you and many others that have helped bring the field to this point.
Warm regards,
Shams
--
You received this message because you are subscribed to the Google Groups "Lifeboat Foundation Advisory Boards" group.
To unsubscribe from this group and stop receiving emails from it, send an email to lifeboat-advisory-...@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/lifeboat-advisory-boards/CAMLVB1bLChAnC00hCAtd0OCHtgCB%3DUtvZetjVCyTBsfe%3Dk9jxA%40mail.gmail.com.
Paul Werbos
--
José Rafael Castro Fuentes
Francisco Martinez
--